135 related articles for article (PubMed ID: 28803608)
1. Identification of simvastatin-regulated targets associated with JNK activation in DU145 human prostate cancer cell death signaling.
Jung EJ; Chung KH; Kim CW
BMB Rep; 2017 Sep; 50(9):466-471. PubMed ID: 28803608
[TBL] [Abstract][Full Text] [Related]
2. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
Mhaidat NM; Zhang XD; Jiang CC; Hersey P
Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
[TBL] [Abstract][Full Text] [Related]
4. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.
Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S
Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase.
Koyuturk M; Ersoz M; Altiok N
Neurosci Lett; 2004 Nov; 370(2-3):212-7. PubMed ID: 15488325
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of SP600125-controlled TrkA-dependent targets in SK-N-MC neuroblastoma cells: inhibition of TrkA activity by SP600125.
Jung EJ; Park HC; Chung KH; Kim CW
Proteomics; 2014 Feb; 14(2-3):202-15. PubMed ID: 24375967
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of novel targets associated with the enhancement of TrkA-induced SK-N-MC cancer cell death caused by NGF.
Jung EJ; Chung KH; Bae DW; Kim CW
Exp Mol Med; 2016 May; 48(5):e235. PubMed ID: 27229480
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway.
Gopalan A; Yu W; Sanders BG; Kline K
Cancer Lett; 2013 Feb; 329(1):9-16. PubMed ID: 22960596
[TBL] [Abstract][Full Text] [Related]
9. The sequential combination of a JNK inhibitor and simvastatin protects porcine islets from peritransplant apoptosis and inflammation.
Jin SM; Kim KS; Lee SY; Gong CH; Park SK; Shin JS; Park CG; Kim SJ
Cell Transplant; 2011; 20(7):1139-51. PubMed ID: 21176401
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
Yoo J; Park SS; Lee YJ
J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
[TBL] [Abstract][Full Text] [Related]
11. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
13. Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.
Kim Y; Lee EJ; Jang HK; Kim CH; Kim DG; Han JH; Park SM
J Gastroenterol Hepatol; 2016 Jun; 31(6):1220-8. PubMed ID: 26574150
[TBL] [Abstract][Full Text] [Related]
14. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
15. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
[TBL] [Abstract][Full Text] [Related]
16. c-Jun N-terminal kinase phosphorylation of heterogeneous nuclear ribonucleoprotein K regulates vertebrate axon outgrowth via a posttranscriptional mechanism.
Hutchins EJ; Szaro BG
J Neurosci; 2013 Sep; 33(37):14666-80. PubMed ID: 24027268
[TBL] [Abstract][Full Text] [Related]
17. Distinct signaling pathways of microtubule inhibitors--vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively.
Kolomeichuk SN; Terrano DT; Lyle CS; Sabapathy K; Chambers TC
FEBS J; 2008 Apr; 275(8):1889-99. PubMed ID: 18341588
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue.
Yoshimura K; Nagasawa A; Kudo J; Onoda M; Morikage N; Furutani A; Aoki H; Hamano K
Int J Mol Sci; 2015 May; 16(5):11213-28. PubMed ID: 25993292
[TBL] [Abstract][Full Text] [Related]
19. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.
Singh SV; Choi S; Zeng Y; Hahm ER; Xiao D
Cancer Res; 2007 Aug; 67(15):7439-49. PubMed ID: 17671214
[TBL] [Abstract][Full Text] [Related]
20. c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Prostate; 2003 Jun; 55(4):265-80. PubMed ID: 12712406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
